Also trades as: 4151.T (JPX) · $vol 20M

$14.05

-0.66 (-4.49%)

Weekly Expected Move ±4.9%

$13 $13 $14 $15 $15

OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 53 · $7.4B mcap · 233M float · 0.0001% daily turnover · Short 61% of daily vol

Revenue

$497.3B +0.3% ▲

5Y CAGR: +9.3%

Gross Profit

$369.2B +1.7% ▲

5Y CAGR: +9.2%

Operating Income

$102.4B +11.4% ▲

5Y CAGR: +11.7%

Net Income

$67.1B +12.1% ▲

5Y CAGR: +7.4%

EPS (Diluted)

$128.18 +13.4% ▲

5Y CAGR: +7.9%

EBITDA

$116.3B +0.5% ▲

5Y CAGR: +9.3%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$352.2B	$398.4B	$442.2B	$495.6B	$497.3B
YoY Growth	+10.6%	+13.1%	+11.0%	+12.1%	+0.3%
Cost of Revenue	$87.8B	$86.9B	$111.2B	$132.6B	$128.0B
Gross Profit	$264.4B	$311.5B	$331.0B	$362.9B	$369.2B
Gross Margin	75.1%	78.2%	74.9%	73.2%	74.2%
R&D Expenses	$57.7B	$62.9B	$81.5B	$103.5B	$101.3B
SG&A Expenses	$135.1B	$166.2B	$163.1B	$167.5B	$165.6B
Operating Expenses	$203.3B	$246.6B	$244.6B	$271.1B	$266.8B
Operating Income	$61.2B	$82.4B	$86.4B	$91.9B	$102.4B
Operating Margin	17.4%	20.7%	19.5%	18.5%	20.6%
Interest Expense	$1.1B	$1.1B	$190M	$7.5B	$3.6B
Income Before Tax	$60.0B	$67.6B	$97.2B	$83.5B	$87.3B
Tax Expense	$7.7B	$14.0B	$16.1B	$23.6B	$20.2B
Net Income	$52.3B	$53.6B	$81.2B	$59.9B	$67.1B
Net Margin	14.9%	13.4%	18.4%	12.1%	13.5%
EPS (Diluted)	$97.39	$99.66	$151.01	$113.06	$128.18
EBITDA	$79.9B	$87.1B	$113.0B	$115.8B	$116.3B
Shares Outstanding	538M	538M	538M	530M	523M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$129.8B	$132.8B	$104.7B	$125.9B	$120.5B	$146.1B	$119.2B	$144.1B
Cost of Revenue	$34.5B	$38.6B	$24.6B	$37.3B	$28.6B	$37.6B	$33.2B	$38.8B
Gross Profit	$95.3B	$94.2B	$80.1B	$88.7B	$91.9B	$109.6B	$86.0B	$105.3B
Gross Margin	73.4%	70.9%	76.5%	70.4%	76.3%	75.0%	72.1%	73.0%
R&D Expenses	$25.0B	$29.2B	$28.6B	$23.9B	$24.7B	$24.4B	$27.3B	$19.0B
SG&A Expenses	$40.4B	$32.2B	$42.0B	$40.8B	$39.3B	$43.9B	$41.3B	$43.4B
Operating Expenses	$136.3B	$2.3B	$70.6B	$55.2B	$64.0B	$68.3B	$68.7B	$62.4B
Operating Income	-$41.0B	$91.9B	$9.5B	$33.5B	$27.9B	$31.4B	$17.3B	$42.8B
Operating Margin	-31.6%	69.2%	9.1%	26.6%	23.2%	21.5%	14.5%	29.7%
Interest Expense	$1.9B	$0	$0	$1.2B	$537M	$435M	$2.3B	$0
Income Before Tax	$25.1B	$11.9B	$7.9B	$14.1B	$26.3B	$39.0B	$14.0B	$23.4B
Tax Expense	$6.9B	$7.9B	$1.7B	$4.0B	$9.8B	$4.7B	$1.9B	$4.9B
Net Income	$18.1B	$4.0B	$6.2B	$10.2B	$16.5B	$34.3B	$12.1B	$18.4B
Net Margin	14.0%	3.0%	5.9%	8.1%	13.7%	23.5%	10.2%	12.8%
EPS (Diluted)	$34.43	$7.57	$11.78	$19.40	$31.54	$65.46	$22.37	$35.52
EBITDA	$36.8B	$25.3B	$15.6B	$17.8B	$33.9B	$48.9B	$25.0B	$50.5B
Shares Outstanding	525M	524M	524M	523M	523M	523M	523M	524M

KYKOF OTC